Richard S Geary Ionis Pharmaceuticals Inc (IONS) insider trading activity

Richard S Geary is EVP, Chief Development Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 59,657 shares of IONS, which is worth approximately $4.27 Million. The most recent transaction as insider was on Nov 06, 2025, when has been sold 33,038 shares (Common Stock) at a price of $75.76 per share, resulting in proceeds of $2,502,958. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.7K

25.11% 3M change

29.68% 12M change

Total Value Held $4.27 Million

Richard S Geary Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 06 2025	SELL Open market or private sale	$2,502,958 $75.76 p/Share	33,038 Reduced 35.64%	59,657 Common Stock
Nov 06 2025	BUY Exercise of conversion of derivative security	$1,943,625 $58.83 p/Share	33,038 Added 29.77%	77,957 Common Stock
Nov 05 2025	SELL Open market or private sale	$120,091 $75.01 p/Share	1,601 Reduced 2.61%	59,657 Common Stock
Nov 05 2025	BUY Exercise of conversion of derivative security	$94,186 $58.83 p/Share	1,601 Added 2.58%	60,458 Common Stock
Nov 03 2025	SELL Open market or private sale	$126,084 $75.05 p/Share	1,680 Reduced 2.74%	59,657 Common Stock
Nov 03 2025	BUY Exercise of conversion of derivative security	$98,834 $58.83 p/Share	1,680 Added 2.7%	60,562 Common Stock
Oct 31 2025	SELL Open market or private sale	$6,703,492 $75.11 p/Share	89,249 Reduced 59.94%	59,657 Common Stock

Oct 31 2025	BUY Exercise of conversion of derivative security	$4,073,918 $58.83 p/Share	69,249 Added 37.72%	114,321 Common Stock
Sep 30 2025	SELL Open market or private sale	$3,777,395 $65.24 p/Share	57,900 Reduced 42.09%	79,657 Common Stock
Sep 30 2025	BUY Exercise of conversion of derivative security	$3,113,283 $53.77 p/Share	57,900 Added 29.62%	137,557 Common Stock
Sep 02 2025	SELL Open market or private sale	$503,700 $50.37 p/Share	10,000 Reduced 11.15%	79,657 Common Stock
Aug 29 2025	BUY Other acquisition or disposition	$4,572 $27.71 p/Share	165 Added 0.18%	89,657 Common Stock
Aug 05 2025	SELL Open market or private sale	$428,600 $42.86 p/Share	10,000 Reduced 10.05%	89,492 Common Stock
Feb 28 2025	BUY Other acquisition or disposition	$11,707 $28.21 p/Share	415 Added 0.42%	99,492 Common Stock
Jan 31 2025	SELL Open market or private sale	$45,554 $32.4 p/Share	1,406 Reduced 1.4%	99,077 Common Stock
Jan 30 2025	BUY Grant, award, or other acquisition	-	3,820 Added 3.66%	100,483 Common Stock
Jan 16 2025	SELL Open market or private sale	$232,385 $32.86 p/Share	7,072 Reduced 6.82%	96,663 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	-	18,901 Added 15.41%	103,735 Common Stock
Aug 30 2024	BUY Other acquisition or disposition	$425 $38.64 p/Share	11 Added 0.01%	84,834 Common Stock
Aug 29 2024	SELL Open market or private sale	$16,427 $49.63 p/Share	331 Reduced 0.39%	84,823 Common Stock
Aug 28 2024	SELL Open market or private sale	$15,731 $49.16 p/Share	320 Reduced 0.37%	85,154 Common Stock
Aug 05 2024	SELL Open market or private sale	$116,640 $48.0 p/Share	2,430 Reduced 2.76%	85,508 Common Stock
Feb 29 2024	BUY Other acquisition or disposition	$20,789 $34.42 p/Share	604 Added 0.68%	87,938 Common Stock
Feb 02 2024	SELL Open market or private sale	$98,128 $50.04 p/Share	1,961 Reduced 2.2%	87,334 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	3,820 Added 4.1%	89,295 Common Stock

RSG

Richard S Geary

EVP, Chief Development Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account